Prostate-specific antigen screening and prostate cancer treatment in renal transplantation candidates: A survey of U.S. transplantation centers

•Our survey shows variation in CaP screening and treatment practices.•A high percentage of respondents report AS as a viable option.•Most use a risk-based approach to determine time to eligibility after treatment.•Care of these unique patients may benefit from a consensus panel.